Literature DB >> 32572241

Tet2 and Tet3 in B cells are required to repress CD86 and prevent autoimmunity.

Shinya Tanaka1,2,3, Wataru Ise1, Takeshi Inoue1, Ayako Ito1, Chisato Ono2, Yoshihito Shima4, Shuhei Sakakibara5, Manabu Nakayama6, Kentaro Fujii1, Ikuo Miura7, Jafar Sharif8, Haruhiko Koseki8,9, Pandelakis A Koni10, Indu Raman11, Quan-Zhen Li11, Masato Kubo3,12, Katsunori Fujiki13, Ryuichiro Nakato13, Katsuhiko Shirahige13, Hiromitsu Araki14, Fumihito Miura14, Takashi Ito14, Eiryo Kawakami15,16, Yoshihiro Baba17,18, Tomohiro Kurosaki19,20.   

Abstract

A contribution of epigenetic modifications to B cell tolerance has been proposed but not directly tested. Here we report that deficiency of ten-eleven translocation (Tet) DNA demethylase family members Tet2 and Tet3 in B cells led to hyperactivation of B and T cells, autoantibody production and lupus-like disease in mice. Mechanistically, in the absence of Tet2 and Tet3, downregulation of CD86, which normally occurs following chronic exposure of self-reactive B cells to self-antigen, did not take place. The importance of dysregulated CD86 expression in Tet2- and Tet3-deficient B cells was further demonstrated by the restriction, albeit not complete, on aberrant T and B cell activation following anti-CD86 blockade. Tet2- and Tet3-deficient B cells had decreased accumulation of histone deacetylase 1 (HDAC1) and HDAC2 at the Cd86 locus. Thus, our findings suggest that Tet2- and Tet3-mediated chromatin modification participates in repression of CD86 on chronically stimulated self-reactive B cells, which contributes, at least in part, to preventing autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32572241     DOI: 10.1038/s41590-020-0700-y

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  55 in total

1.  Central B-cell tolerance: where selection begins.

Authors:  Roberta Pelanda; Raul M Torres
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-04-01       Impact factor: 10.005

Review 2.  Transgenic mice and analysis of B-cell tolerance.

Authors:  C C Goodnow
Journal:  Annu Rev Immunol       Date:  1992       Impact factor: 28.527

Review 3.  Mechanisms of central tolerance for B cells.

Authors:  David Nemazee
Journal:  Nat Rev Immunol       Date:  2017-04-03       Impact factor: 53.106

Review 4.  Cellular and genetic mechanisms of self tolerance and autoimmunity.

Authors:  Christopher C Goodnow; Jonathon Sprent; Barbara Fazekas de St Groth; Carola G Vinuesa
Journal:  Nature       Date:  2005-06-02       Impact factor: 49.962

Review 5.  An epigenetic view of B-cell disorders.

Authors:  Federica Alberghini; Valentina Petrocelli; Mahshid Rahmat; Stefano Casola
Journal:  Immunol Cell Biol       Date:  2015-01-20       Impact factor: 5.126

Review 6.  Altered B cell signalling in autoimmunity.

Authors:  David J Rawlings; Genita Metzler; Michelle Wray-Dutra; Shaun W Jackson
Journal:  Nat Rev Immunol       Date:  2017-04-10       Impact factor: 53.106

Review 7.  Sites and stages of autoreactive B cell activation and regulation.

Authors:  Mark J Shlomchik
Journal:  Immunity       Date:  2008-01       Impact factor: 31.745

Review 8.  B-cell anergy: from transgenic models to naturally occurring anergic B cells?

Authors:  John C Cambier; Stephen B Gauld; Kevin T Merrell; Barbara J Vilen
Journal:  Nat Rev Immunol       Date:  2007-07-20       Impact factor: 53.106

Review 9.  DNA methylation and autoimmune disease.

Authors:  Bruce Richardson
Journal:  Clin Immunol       Date:  2003-10       Impact factor: 3.969

Review 10.  Epigenetic regulation in B-cell maturation and its dysregulation in autoimmunity.

Authors:  Haijing Wu; Yaxiong Deng; Yu Feng; Di Long; Kongyang Ma; Xiaohui Wang; Ming Zhao; Liwei Lu; Qianjin Lu
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

View more
  25 in total

1.  Targeting BMI-1 in B cells restores effective humoral immune responses and controls chronic viral infection.

Authors:  Andrea Di Pietro; Jack Polmear; Lucy Cooper; Timon Damelang; Tabinda Hussain; Lauren Hailes; Kristy O'Donnell; Vibha Udupa; Tian Mi; Simon Preston; Areen Shtewe; Uri Hershberg; Stephen J Turner; Nicole L La Gruta; Amy W Chung; David M Tarlinton; Christopher D Scharer; Kim L Good-Jacobson
Journal:  Nat Immunol       Date:  2021-11-29       Impact factor: 25.606

2.  Jmjd1c demethylates STAT3 to restrain plasma cell differentiation and rheumatoid arthritis.

Authors:  Yuye Yin; Xinyi Yang; Shusheng Wu; Xinyu Ding; Huamin Zhu; Xuehui Long; Yuliang Wang; Sulan Zhai; Yun Chen; Nan Che; Jingjing Chen; Xiaoming Wang
Journal:  Nat Immunol       Date:  2022-08-22       Impact factor: 31.250

Review 3.  Epigenetic regulation of B cells and its role in autoimmune pathogenesis.

Authors:  Fan Xiao; Ke Rui; Xiaofei Shi; Haijing Wu; Xiaoyan Cai; Kathy O Lui; Qianjin Lu; Esteban Ballestar; Jie Tian; Hejian Zou; Liwei Lu
Journal:  Cell Mol Immunol       Date:  2022-10-12       Impact factor: 22.096

4.  Epigenetic remodeling by vitamin C potentiates plasma cell differentiation.

Authors:  Heng-Yi Chen; Ana Almonte-Loya; Fang-Yun Lay; Michael Hsu; Eric Johnson; Edahí González-Avalos; Jieyun Yin; Richard S Bruno; Qin Ma; Hazem E Ghoneim; Daniel J Wozniak; Fiona E Harrison; Chan-Wang Jerry Lio
Journal:  Elife       Date:  2022-09-07       Impact factor: 8.713

5.  Post-bisulfite Adaptor Tagging with a Highly Efficient Single-Stranded DNA Ligation Technique.

Authors:  Fumihito Miura; Takashi Ito
Journal:  Methods Mol Biol       Date:  2023

6.  nMOWChIP-seq: low-input genome-wide mapping of non-histone targets.

Authors:  Zhengzhi Liu; Lynette B Naler; Yan Zhu; Chengyu Deng; Qiang Zhang; Bohan Zhu; Zirui Zhou; Mimosa Sarma; Alexander Murray; Hehuang Xie; Chang Lu
Journal:  NAR Genom Bioinform       Date:  2022-04-07

Review 7.  Importance of clonal hematopoiesis in heart failure.

Authors:  Nicholas W Chavkin; Kyung-Duk Min; Kenneth Walsh
Journal:  Trends Cardiovasc Med       Date:  2021-04-20       Impact factor: 6.677

Review 8.  Recent Advances in Lupus B Cell Biology: PI3K, IFNγ, and Chromatin.

Authors:  Maria A Bacalao; Anne B Satterthwaite
Journal:  Front Immunol       Date:  2021-01-14       Impact factor: 7.561

Review 9.  TETology: Epigenetic Mastermind in Action.

Authors:  Ashikh Seethy; Karthikeyan Pethusamy; Indranil Chattopadhyay; Ramkishor Sah; Anita Chopra; Ruby Dhar; Subhradip Karmakar
Journal:  Appl Biochem Biotechnol       Date:  2021-03-10       Impact factor: 2.926

10.  TET2 Inhibits PD-L1 Gene Expression in Breast Cancer Cells through Histone Deacetylation.

Authors:  Yinghui Shen; Lu Liu; Mengyuan Wang; Bo Xu; Ruitu Lyu; Yujiang Geno Shi; Li Tan
Journal:  Cancers (Basel)       Date:  2021-05-04       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.